Gladstone Investment Corporation reports today with a positioning picture that is notably relaxed — short sellers have been covering steadily, borrow conditions remain loose, and options traders are skewing toward calls rather than protection.
The clearest signal heading into the print is that bearish conviction has been draining away. Short interest has fallen roughly 15% over the past month, with shares short dropping to around 586,000. That decline accelerated through the week, with a further 13% shed in the past seven days alone. Borrow conditions confirm there is no pressure on remaining shorts: availability is running at over 1,600% — meaning lenders hold roughly sixteen shares for every one currently borrowed — one of the most relaxed readings the stock has seen all year. The ORTEX short score has also retreated sharply, falling from around 46 in late July to 33.7 now, signaling that the aggregate short-side setup has unwound considerably into earnings day.
Options positioning tells the same story. With the put/call ratio at just 0.061 — well below its 20-day average of 0.078 and near the lowest reading of the past year — traders are running call-heavy into the print. That's more than one standard deviation below the recent mean, placing it at the bullish extreme of recent history. The stock itself has backed the move, gaining 8% over the past month and adding nearly 4% across the past week to close at $16.86, outperforming BDC peers including , , and , which were all flat to slightly higher on the week.
The analyst debate carries a notable tension. Oppenheimer raised its target to $17 in May — essentially at the current price — while maintaining an Outperform rating, suggesting the Street's most constructive voice sees limited upside from here at current levels. The consensus mean target of $13.90 is worth treating with caution: it reflects data through mid-2025 and sits well below the stock's current trade, implying the Street has not collectively re-rated the name despite its move higher. Cost to borrow has crept up 17% over the past week to 3.5%, a modest but notable uptick that bears watching if sentiment shifts post-print.
On the institutional side, Two Sigma added over 614,000 shares in Q1 — more than doubling its position — while Van Eck added nearly 190,000 shares as recently as July, giving the stock fresh institutional backing at prices consistent with the current level. The CFO made small open-market purchases in May around $16, adding a directional signal from inside the firm itself, though the transaction sizes were token rather than material.
The earnings release is therefore less about whether shorts are repositioning — they already have — and more about whether the underlying portfolio quality and net asset value can justify a stock now trading at the top end of recent analyst expectations.
See the live data behind this article on ORTEX.
Open GAIN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.